Tag: immunotherapy

Viaskin Peanut

DBV Technologies Announces FDA Acceptance of BLA filing for Viaskin Peanut...

If approved, Viaskin Peanut would be the first and only epicutaneous immunotherapy indicated for this potentially life-threatening condition in children.
Patient Undergoing SLIT

New Peanut Allergy Treatment Passes Phase 2 Trial, Shows Effectiveness and...

UNC School of Medicine researchers show that tiny under-the-tongue doses of peanut protein can offer safe and substantial protection against peanut allergy.
FARE Reponse to ICER Report

Fare Responds to Final ICER Review of Breakthrough Peanut Allergy Therapies

FARE expresses its deep concerns with the final evidence report on two breakthrough peanut allergy therapies issued Wednesday by ICER.
AAFA Reponse to ICER Report

Asthma and Allergy Foundation of America Responds to Premature ICER Review...

The AAFA addresses concerns regarding the Final Evidence Report released by the ICER.
AAFA Press Release Regarding ICER Review

Asthma and Allergy Foundation of America Elevates Patient Voice in ICER...

Affirms Burden of Food Allergies on Families, Patients, and Caregivers.
Dr Kari Nadeau

Must Hear: Interview with Stanford Immunologist Dr Kari Nadeau – Defeating...

Dr Kari Nadeau, who runs the Sean Parker Center for Allergy and Asthma Research at Stanford University, takes us on a tour...
Researchers

Phase I Trial for New Peanut Allergy Immunotherapy Results in No...

Research details phase one study of peptide-based immunotherapy, which is designed to remove risks of acute reactions during treatment.
Vedanta Immunomodulator

Company Developing Microbiome-Derived Food Allergy Therapy Raises $27 Million

Product candidate being developed may safely induce permanent tolerance to food allergens.
OIT

Study: Immunotherapy Trials for Food Allergy Hold Strong Appeal for Parents

Child’s food allergies have major impact on parents’ lives; majority of parents are willing to enroll their child in an immunotherapy clinical trial
Test Tubes

Adult Peanut Allergy: Therapy Cleared to Begin Phase IIa Trials

Antibody targets trigger also implicated in other food allergies, atopic diseases, and asthma.

Connect with Us

40,035FansLike
960FollowersFollow
2,765FollowersFollow
5,603FollowersFollow
42SubscribersSubscribe